Electrochemically Synthesized MIP Sensors: Applications in Healthcare Diagnostics

Akinrinade George Ayankojo,Jekaterina Reut,Vitali Syritski

DOI: https://doi.org/10.3390/bios14020071

2024-01-30

Biosensors

Abstract:Early-stage detection and diagnosis of diseases is essential to the prompt commencement of treatment regimens, curbing the spread of the disease, and improving human health. Thus, the accurate detection of disease biomarkers through the development of robust, sensitive, and selective diagnostic tools has remained cutting-edge scientific research for decades. Due to their merits of being selective, stable, simple, and having a low preparation cost, molecularly imprinted polymers (MIPs) are increasingly becoming artificial substitutes for natural receptors in the design of state-of-the-art sensing devices. While there are different MIP preparation approaches, electrochemical synthesis presents a unique and outstanding method for chemical sensing applications, allowing the direct formation of the polymer on the transducer as well as simplicity in tuning the film properties, thus accelerating the trend in the design of commercial MIP-based sensors. This review evaluates recent achievements in the applications of electrosynthesized MIP sensors for clinical analysis of disease biomarkers, identifying major trends and highlighting interesting perspectives on the realization of commercial MIP-endowed testing devices for rapid determination of prevailing diseases.

chemistry, analytical,nanoscience & nanotechnology,instruments & instrumentation

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is how to achieve accurate detection of disease biomarkers in medical diagnosis by developing robust, sensitive and selective sensing tools. Specifically, the article focuses on the application of electrochemically synthesized molecularly imprinted polymer (MIP) sensors in medical diagnosis, aiming to overcome the limitations of using unstable biological receptors as recognition elements in existing biosensing systems and providing a more stable, lower - cost and easier - to - operate alternative.

### Main problems and solutions

1. **Early disease detection and diagnosis**:
- Early detection and diagnosis of diseases are crucial for starting treatment in a timely manner, controlling the spread of diseases and improving human health.
- Existing biosensing systems rely on unstable biological receptors, which limit the shelf life of the device and increase the overall cost.

2. **Developing new sensing tools**:
- **Molecularly imprinted polymers (MIPs)**: MIPs are artificially synthesized receptors with the advantages of strong selectivity, high stability, simple preparation and low cost.
- **Electrochemical synthesis method**: The method of electrochemically synthesizing MIPs allows the formation of polymer thin films directly on the sensor transducer, and the film thickness and internal morphology can be precisely controlled by adjusting the charge amount, thus accelerating the design of commercial MIP sensors.

3. **Improving detection sensitivity and selectivity**:
- To improve the detection sensitivity of small and large molecules (such as proteins), researchers have adopted a variety of strategies, including nano - scale design, combining nanomaterials (such as carbon nanotubes, graphene and metal nanoparticles), and surface imprinting techniques.
- For large molecules (such as proteins), the traditional "bulk" imprinting method may cause the template molecules to be completely wrapped in the polymer and difficult to remove. Therefore, surface imprinting techniques and epitope imprinting techniques have been widely studied and applied to ensure that the template molecules can be successfully removed and selective binding sites are formed on the polymer surface.

### Application fields

- **Cancer**: Detection of tumor markers such as CEA, CA15 - 3, etc.
- **Cardiovascular diseases**: Detection of markers of myocardial infarction, etc.
- **Inflammatory diseases**: Detection of C - reactive protein, etc.
- **Neurological diseases**: Detection of neuron - specific enolase (NSE), etc.
- **Infectious diseases**: Detection of SARS - CoV - 2 virus proteins, etc.

Through the application of these methods and techniques, electrochemically synthesized MIP sensors can provide fast, reliable and highly sensitive detection of disease biomarkers in clinical analysis, providing new possibilities for personalized medicine and point - of - care testing (POCT).